Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Forearm, wrist and hand complaints.

BIBLIOGRAPHIC SOURCE(S)

  • Forearm, wrist, and hand complaints. Elk Grove Village (IL): American College of Occupational and Environmental Medicine (ACOEM); 2004. 34 p. [101 references]

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Harris, J, ed. Occupational Medicine Practice Guidelines: American College of Occupational and Environmental Medicine. Beverly Farms, MA: OEM Press; 1997.

** REGULATORY ALERT **

FDA WARNING/REGULATORY ALERT

Note from the National Guideline Clearinghouse: This guideline references a drug(s) for which important revised regulatory information has been released.

BRIEF SUMMARY CONTENT

 ** REGULATORY ALERT **
 RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Recommendations are followed by evidence classification (A-D) identifying the type of supporting evidence. Definitions for the types of evidence are presented at the end of the "Major Recommendations" field.

Summary of Recommendations for Evaluating and Managing Forearm, Wrist, and Hand Complaints (refer to the original guideline document for more detailed information)

Clinical Measure Recommended Optional Not Recommended
History and physical exam Basic history, focused exam, and search for red flags (C)    
Patient education Patient education regarding prevention, diagnosis, prognosis, and expectations of medical treatment (D)    
Medication (See Chapter 3 in the original guideline document) Acetaminophen (C)

Non-steroidal anti-inflammatory drugs (NSAIDs) (B)
Opioids, short course (C)

Rarely, corticosteroids (C)
Use of opioids for more than 2 weeks (C)
Physical treatment methods Instructions for home exercises At-home applications of heat or cold packs (D) Passive modalities

Transcutaneous electrical neurostimulation (TENS) units (C)

Biofeedback (D)
Injections Injection of corticosteroids into carpal tunnel in mild or moderate cases of carpal tunnel syndrome (CTS) after trial of splinting and medication (C)

Initial injection into tendon sheath for clearly diagnosed cases of DeQuervain's syndrome, tenosynovitis, or trigger finger (D)
Initial injection of corticosteroids in moderate cases of tendinitis (D) Repeated or frequent injection of corticosteroids into carpal tunnel, tendon sheaths, ganglia, etc. (D)
Rest and immobilization Splinting as first-line conservative treatment for carpal tunnel syndrome, DeQuervain's syndrome, strains, etc. (C) Prolonged splinting (leads to weakness and stiffness) (D)

Prolonged post-operative splinting (C)
 
Activity and exercise Stretching

Aerobic exercise

Maintaining strength and mobility of all remaining body parts while recovering from wrist problems (C)
  Reduced general activities while recovering (D)
Detection of neurologic abnormalities Nerve conduction velocity (NCV) for median (B) or ulnar (C) impingement at the wrist after failure of conservative treatment   Routine use of NCV or electromyography (EMG) in diagnostic evaluation of nerve entrapment or screening in patients w/o symptoms (D)

Use of vibrometry for screening (C)
Radiography Plain films for suspected scaphoid fractures, repeat films in 7-10 days (D) Limited bone scan to detect fractures if clinical suspicion exists (C) Routine use for evaluation of forearm, wrist, and hand (D)
Other imaging procedures   Use of arthrography, magnetic resonance imaging (MRI), or computed tomography (CT) scans prior to history and physical examination by a qualified specialist (D)  
Surgical considerations Early surgical intervention for severe carpal tunnel syndrome (CTS) confirmed by NCV may be indicated (B)

Tendinitis (DeQuervain's), ganglion, or trigger finger: referral to surgeon only after patient education and conservative treatment, including splinting and injection, have failed (C, D)
   
Psychosocial factors Consider counseling for severe hand injuries (D)

Awareness by treating practitioner of interplay between physical, economic, and psychological factors in patients with muscular skeletal disorders (MSDs) (C, D)
   

Definitions:

Levels of Evidence

A = Strong research-based evidence (multiple relevant, high-quality scientific studies).

B = Moderate research-based evidence (one relevant, high-quality scientific study or multiple adequate scientific studies).

C = Limited research-based evidence (at least one adequate scientific study of patients with forearm, wrist, or hand disorders).

D = Reviewer or consensus interpretation of evidence not meeting inclusion criteria for research-based evidence.

CLINICAL ALGORITHM(S)

The following clinical algorithms are provided in the original guideline document:

  • American College of Occupational and Environmental Medicine Guidelines for care of acute and subacute occupational forearm, wrist, and hand complaints
  • Initial evaluation of occupational forearm, wrist, and hand complaints
  • Initial and follow-up management of occupational forearm, wrist, and hand complaints
  • Evaluation of slow-to-recover patients with occupational forearm, wrist, and hand complaints (symptoms >4 weeks)
  • Surgical considerations for patients with anatomic and physiologic evidence of nerve root compression and persistent forearm, wrist, and hand symptoms
  • Further management of occupational forearm, wrist, and hand complaints

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of supporting evidence is identified and graded for each recommendation (see "Major Recommendations").

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • Forearm, wrist, and hand complaints. Elk Grove Village (IL): American College of Occupational and Environmental Medicine (ACOEM); 2004. 34 p. [101 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

1997 (revised 2004)

GUIDELINE DEVELOPER(S)

American College of Occupational and Environmental Medicine - Medical Specialty Society

SOURCE(S) OF FUNDING

American College of Occupational and Environmental Medicine

GUIDELINE COMMITTEE

American College of Occupational and Environmental Medicine Practice Guidelines Committee

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Chapter Lead: C. David Rowlett, MD, MS

Committee Members: Jennifer H. Christian, MD, MPH, FACPM; Philip I. Harber, MD, MPH, FACOEM, FCCP; John P. Holland, MD, MPH, FACOEM; Kathryn L. Mueller, MD, MPH, FACEP, FACOEM; Douglas J. Patron, MD, MSPH; Bernyce M. Peplowski, DO, MS; and Jack Richman, MD, CCFP, DOHS, FACOEM

Timothy J. Key, MD, MPH, FACOEM, as Responsible Officer and ACOEM President Elect, and Edward A. Emmett, MD, MS, FACOEM, Chair of the ACOEM Council on Occupational and Environmental Medical Practice, contributed to the development of the guidelines as well.

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Harris, J, ed. Occupational Medicine Practice Guidelines: American College of Occupational and Environmental Medicine. Beverly Farms, MA: OEM Press; 1997.

GUIDELINE AVAILABILITY

AVAILABILITY OF COMPANION DOCUMENTS

None available

PATIENT RESOURCES

None available

NGC STATUS

This NGC summary was completed by ECRI on May 31, 2006. The information was verified by the guideline developer on November 3, 2006.

COPYRIGHT STATEMENT

The American College of Occupational and Environmental Medicine, the signator of this license, represent and warrant that they are the publisher of the guidelines and/or possess all rights necessary to grant the license rights to AHRQ and its agents.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo